{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:53:31Z","timestamp":1788666811395,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301583"],"award-info":[{"award-number":["82301583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.imbio.2026.153192","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:04:59Z","timestamp":1779984299000},"page":"153192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The alterations of blood immune subpopulations, cytokines, and metabolites in anti-acetylcholine receptor antibody-positive myasthenia gravis: a real-world, observational, high-throughput study"],"prefix":"10.1016","volume":"231","author":[{"given":"Huanyu","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingkun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2026.153192_bb0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.autrev.2009.02.014","article-title":"Regulatory T cells in diabetes and gastritis","volume":"8","author":"Alonso","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2026.153192_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2026.153192_bb0015","article-title":"On the road to blood biomarkers in myasthenia gravis (MG): beyond clinical scales","author":"Bhandage","year":"2025","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.imbio.2026.153192_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.imbio.2026.153192_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2006.06.031","article-title":"Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation","volume":"180","author":"Cepok","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147566","article-title":"The FoxO4\/DKK3 axis represses IFN-gamma expression by Th1 cells and limits antimicrobial immunity","volume":"132","author":"Chen","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2026.153192_bb0035","article-title":"Therapeutic potential of TNFR2 agonists: a mechanistic perspective","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2026.153192_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1248336","article-title":"Altered gut microbiota and metabolites in untreated myasthenia gravis patients","volume":"14","author":"Ding","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.imbio.2026.153192_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1023\/A:1022572727408","article-title":"Dehydroepiandrosterone therapy ameliorates experimental autoimmune myasthenia gravis in Lewis rats","volume":"23","author":"Duan","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0055","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2026.153192_bb0060","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1007\/s00415-024-12454-6","article-title":"Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis","volume":"271","author":"H\u00e9raud","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.imbio.2026.153192_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.imbio.2026.153192_bb0070","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1038\/s41467-019-10703-1","article-title":"Decreased maternal serum acetate and impaired fetal thymic and regulatory T cell development in preeclampsia","volume":"10","author":"Hu, M., Eviston, D., Hsu, P., Marino, E., Chidgey, A., Santner-Nanan, B., Wong, K., Richards, J.L., Yap, Y.A., Collier, F., Quinton, A., Joung, S., Peek, M., Benzie, R., Macia, L., Wilson, D., Ponsonby, A.L., Tang, M.L.K., O\u2019Hely, M., Daly, N.L., Mackay, C.R., Dahlstrom, J.E., Group, B.I.S.I., Vuillermin, P., Nanan, R","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2026.153192_bb0075","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00401-021-02299-y","article-title":"Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature","volume":"141","author":"Ingelfinger","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.imbio.2026.153192_bb0080","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1073\/pnas.0503168102","article-title":"Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo","volume":"102","author":"Jendreyko","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2026.153192_bb0085","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00110-2019","article-title":"Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue","volume":"55","author":"Jogdand","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.imbio.2026.153192_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/fn.2022.114053","article-title":"Amino acids levels as a potential biomarker in myasthenia gravis","volume":"60","author":"Ko\u015bli\u0144ski","year":"2022","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.imbio.2026.153192_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/1744666X.4.1.43","article-title":"Effect of complement and its regulation on myasthenia gravis pathogenesis","volume":"4","author":"Kusner","year":"2008","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2018.11.006","article-title":"Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients","volume":"312","author":"Li","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.imbio.2026.153192_bb0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.imbio.2026.153192_bb0110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","article-title":"TLR2 and TLR4 in autoimmune diseases: a comprehensive review","volume":"47","author":"Liu","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.imbio.2026.153192_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103875","article-title":"Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells","volume":"24","author":"Man\u00e9-Damas","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2026.153192_bb0125","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1002\/jcb.29686","article-title":"Thrombospondin-5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis","volume":"121","author":"Muqri","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"Suppl. 3","key":"10.1016\/j.imbio.2026.153192_bb0130","first-page":"110","article-title":"Adrenopause","volume":"62","author":"Nawata","year":"2004","journal-title":"Horm. Res."},{"key":"10.1016\/j.imbio.2026.153192_bb0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1471-4892(01)00044-3","article-title":"Eotaxin and asthma","volume":"1","author":"Pease","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.imbio.2026.153192_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.biotechadv.2011.05.014","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists","volume":"30","author":"Peri","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.imbio.2026.153192_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-1281(11)80246-1","article-title":"Cystatin a and B in the development of human squamous epithelia","volume":"88","author":"Pernu","year":"1990","journal-title":"Acta Histochem."},{"key":"10.1016\/j.imbio.2026.153192_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/eji.201646477","article-title":"Lactate at the crossroads of metabolism, inflammation, and autoimmunity","volume":"47","author":"Pucino","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14793","article-title":"Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis","volume":"30","author":"Ruan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.imbio.2026.153192_bb0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2026.153192_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287654","article-title":"Serum metabolomics of treatment response in myasthenia gravis","volume":"18","author":"Sikorski","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.imbio.2026.153192_bb0170","doi-asserted-by":"crossref","unstructured":"Singh, A., Shannon, C.P., Gautier, B., Rohart, F., Vacher, M., Tebbutt, S.J., KA, L.C. 2019. DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics 35, 3055.Doi: https:\/\/doi.org\/10.1093\/bioinformatics\/bty1054.","DOI":"10.1093\/bioinformatics\/bty1054"},{"key":"10.1016\/j.imbio.2026.153192_bb0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2017.06.001","article-title":"Specific and complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune responses","volume":"26","author":"Stienstra","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.imbio.2026.153192_bb0180","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.179.10.6514","article-title":"CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation","volume":"179","author":"Thewissen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.immuni.2024.04.019","article-title":"Classical monocyte ontogeny dictates their functions and fates as tissue macrophages","volume":"57","author":"Trzebanski","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2026.153192_bb0190","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2280973","article-title":"Lactic Acid Regulation: a potential Therapeutic Option in Rheumatoid Arthritis","volume":"2022","author":"Wang","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.imbio.2026.153192_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578572","article-title":"Clinical outcome and peripheral CD4(+) T profile in impending myasthenic crisis: a prospective cohort study","volume":"402","author":"Wang","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imbio.2026.153192_bb0205","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1002\/mus.26707","article-title":"Refractory myasthenia gravis successfully treated with ofatumumab","volume":"60","author":"Waters","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.imbio.2026.153192_bb0210","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16322","article-title":"A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis","volume":"31","author":"Yin","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.imbio.2026.153192_bb0215","article-title":"Bullous pemphigoid-what do we know about the most recent therapies?","volume":"9","author":"Zeng","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.imbio.2026.153192_bb0220","article-title":"TLR4-MyD88-NF-\u03baB signaling imbalances Th17 and Treg cells in thymoma with myasthenia gravis","volume":"27","author":"Zhang","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.imbio.2026.153192_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:46:53Z","timestamp":1783194413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0171298526000380"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153192","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The alterations of blood immune subpopulations, cytokines, and metabolites in anti-acetylcholine receptor antibody-positive myasthenia gravis: a real-world, observational, high-throughput study","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153192"}}